Sean E. Browne - 15 Aug 2025 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Reporting relationship: President and CEO, Director
Issuer ticker: XTNT
Reported as of: 15 Aug 2025
Net transaction value: -$6,681
SEC form: 4
Accepted by SEC: 19 Aug 2025, 16:45:36 UTC
Prior SEC filing: 16 Oct 2024
Next SEC filing: 18 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Amy Culbert, attorney-in-fact

Key filing fact

Sean E. Browne filed Form 4 for Xtant Medical Holdings, Inc. (XTNT) on 19 Aug 2025.

Key facts

This page summarizes Sean E. Browne's Form 4 filing for Xtant Medical Holdings, Inc. (XTNT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 Aug 2025, 16:45.

Change

Previous filing in this sequence was filed on 16 Oct 2024.
Current net transaction value: -$6,681.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001790461 Primary reporting owner

Browne Sean E

Relationship: President and CEO, Director
Address: C/O XTANT MEDICAL HOLDINGS, INC., 664 CRUISER LANE, BELGRADE
Signature: /s/ Amy Culbert, attorney-in-fact
Signature date: 19 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XTNT transaction

Common Stock

Tax liability

Transaction value: $6,681
Shares: -10,605
Change %: -0.48%
Price: $0.6300
Shares after: 2,180,337
Date: 15 Aug 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.

Footnote F2

Includes an aggregate of 818,740 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.